Breaking News, Financial News

Financial Reports: BASi 4Q11

New business wins lead to profitable year

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

BASi 4Q11/FY11 4Q Revenues: $8.2 million (+10%) 4Q Loss: $668,000 (loss of $279,000 in 4Q10) FY Revenues: $33.1 million (+15%) FY Earnings: $543,000 (loss of $2.7 million in 4Q10) Comments: BASi posted its first profitable year since 2007. The 4Q loss was attributed to “the mix of services provided and unusually high general and administrative expense,” according to a company statement. President and chief executive officer Anthony Chilton remarked, “We expanded our sales ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters